|
Ronnie Coleman 7x Mr. Olympia (pictured above) -
"There's a reason why I use LifeWave. IT WORKS."
|
A BRIEF INTRODUCTION TO THE LIFEWAVE TECHNOLOGY AND EXPLANATION OF
THE PHENOMENA ASSOCIATED WITH ITS USE
By David Schmidt, President, LifeWave Products, LLC
OVERVIEW
-
LifeWave is a new technology that consists of orthomolecular organic structures
that passively interact with the human body for the purpose of inducing
electron flow and thermomagnetic frequency modulation.
-
The induced electron flow assists in recruiting calcium ions into the muscle
fiber during the contraction phase, allowing the user to utilize more muscle
fiber during contraction, thereby allowing the LifeWave user to lift heavier
weights.
-
The passive thermomagnetic frequency modulation of the LifeWave technology
creates a condition in which the transport of long chain fatty acids across the
Mitochondrial membrane for subsequant beta-oxidation and energy production is
increased, providing the LifeWave user with increased energy and stamina.
-
In third party tests conducted independently, over 99% of LifeWave users
experienced significant improvements in physical strength after a few minutes
of using LifeWave, with typical increases being 10% and higher.
-
In third party tests conducted independently, over 99% of LifeWave users
experienced significant increases in stamina after a few minutes of using
LifeWave, with typical increases being 25% and higher.
-
All materials in LifeWave have been clinically tested for safety and efficacy,
and are listed under FDA 21 CFR.
-
All LifeWave devices are manufactured at FDA registered facilities.
-
Patent Pending
INTRODUCTION
The LifeWave technology is a new, Patent Pending and innovative approach to
performance enhancement, to increase stamina and energy. The LifeWave device is
presently embodied in the form of a sport patch, and as such is worn by a user
at specific points on the human body in the same fashion as a band aid or
transdermal patch. The LifeWave products contain NO magnets, NO batteries, NO
copper or dissimilar metals, it is NOT a transdermal infusion system or
anything of this nature. Instead, LifeWave utilizes in part a novel arrangement
and proprietary process-construction of FDA listed beneficial orthomolecular
organic compounds to achieve the truly amazing results reported to LifeWave by
users of the products. These orthomolecular organic compounds have been
determined by the FDA to be safe for use in the presence of humans; in
addition, the materials utilized in the ground-breaking research conducted by
LifeWave scientists are more fully described as complex orthomolecular organic
structures that are capable of either thermomagnetic levorotatory action due to
the atom proton energy associated with thermomagnetic fields or thermomagnetic
dextrorotatory action due to the atom proton energy associated with
thermomagnetic fields. In both cases, in the practical embodiments of the
LifeWave devices, the orthomolecular organic materials utilized are arranged
parallel with respect to the plane of thermomagnetic rotation. LifeWave
Products, LLC manufactures the LifeWave Sport Patch devices at FDA registered
facilities that comply with GMP and QSR requirements.
PRINCIPLE - THEORY OF OPERATION
How does the LifeWave technology work? The LifeWave concept is based on the
principle that the atom proton energy associated with human thermomagnetic
fields are capable of interacting with passive orthomolecular organic materials
so long as these materials are arranged parallel to the plane of rotation, with
this arrangement inducing electron flow due to well known and long established
electromotive principles. It is well known in conventional industrial
electrical generators and alternators that electricity is produced as a result
of the relative rotation of magnetic fields in the presence of a conductor such
as copper wire. In the LifeWave technology and device, the human body provides
both the oscillating thermomagnetic field as well as the conductive media
(electrolytes), with the LifeWave device passively interacting with this
thermomagnetic field so as to induce electron flow in the conductive media
through field shaping and resonance feedback effects.
Recently, work performed in the field of thermally induced quantum tunneling
effects have yielded devices capable of thermionic emission at a scale of only
20 nanometers. In these devices, electron or ion emission are due to the
temperature of the emitter, with the rate of emission increasing rapidly with a
resultant increase in temperature. These devices in part mimic conditions
existing at the microscopic level in human beings. In addition, work performed
by Brownridge has demonstrated in the laboratory that either thermal gradients
or static thermal conditions are capable of inducing potential gradients in
certain crystalline organic materials where the enharmonic ionic vibrations of
these materials lack a center of symmetry and as a result produce crystalline
polarization. Again, these systems for producing electron flow and potential
are present at the microscopic level in human beings.
It is well known that hemoglobin is the Iron-containing pigment of the red
blood cells. Its function is to carry Oxygen from the lungs to the tissues. It
is also well known that collagen is a Copper containing, fibrous insoluble
protein in the connective tissue, including skin, bone, ligaments and
cartilage. In addition, human beings possess a natural temperature differential
from the core to the extremities.
In physics, the Seebeck effect describes a phenomena in which when a system
consists of two metals (such as Iron and Copper), with one metal at a higher
temperature than the other, a current flows in the system. The Thomson
thermoelectric effect is the designation of the potential gradient along a
conductor which accompanies a temperature gradient. The thermomagnetic
phenomena arises in that the thermoelectric and thermomagnetic power is
measured by the electromotive force produced by the unit difference of
temperature, in this case the temperature differential from the core to the
extremities. In short, all of the conditions necessary for human beings to
produce thermomagnetic fields and electron flow are present in humans.
The LifeWave technology is a passive device, constructed in a new and
proprietary process-construction of safe and beneficial orthomolecular organic
compounds for the purpose of improving human performance through the
interaction of the device with the human thermomagnetic field, with it being
believed by LifeWave that said interaction of the LifeWave device with the
individual induces an electron flow in the individual. This interaction is not
unlike the effect that occurs in an electrical generator in which electricity
is produced from moving magnets or magnetic fields. In humans, the increase in
electron flow has numerous demonstrable benefits such as an immediate and
measurable increase in physical strength, improved stamina and pain relief.
MAGNETIC AND THERMOMAGNETIC FIELDS
Thermomagnetic fields arise as a result of dissimilar materials forming
junctions along a temperature gradient. The thermoelectric effect has been
known for well over 150 years, and was first discovered by Michael Faraday. In
humans, Iron containing hemoglobin forms microscopic and macroscopic junctions
with copper containing collagen, with these junctions occurring along a
temperature gradient that initiates at the core with a corresponding
temperature drop at the extremities.
Traditional magnetic fields (H) are defined as the region surrounding a moving
charge, such as when electrons move through a conductor. These conditions also
exist within humans, however the focus of this discussion pertains to
thermomagnetics. Furthermore, materials such as Iron that are capable of being
magnetized permanently are defined as being ferromagnetic (results from
parallel alignment of neighboring magnetic dipoles) and materials such as
Copper are defined as being diamagnetic (nonpermanent magnetism where the
magnetic susceptibility is negative; diamagnetism is expressed vividly in
superconductivity). Thermomagnetic fields, however, are distinguished from both
ferromagnetic phenomena and diamagnetic behavior in that the thermomagnetic
field produced is not the result of alignment of magnetic dipoles but rather
the result of a thermally induced condition of electron charges moving through
a conductor.
As a case in point, if we were to take a bar of Copper and maintain a
temperature gradient from one end to the other, if the hot side was high enough
a thermal increase in kinetic energy of the outer orbit electrons would occur
and allow the electrons to discharge into space. In practice, due to the
electrical conductivity of Copper, the electrons shift in tremendous quantity
to the cool side of the Copper bar with the heat propagation velocity. Excited
electrons on the cool side will now travel toward the hot side encircling the
Copper bar by gyroscopic phenomena. The result is low voltage (millivolts) at
high current.
In experiments performed that were designed to produce very large
thermomagnetic fields (10000 Gauss), conditions have been achieved in which the
EMF of a ring containing Iron and Copper junctions (at a thermal gradient)
traveled in linear velocity equal to the heat propagation, with the resulting
kinetic energy in the orbital electron spinning being so great that electron
shells travel on the same orbital plane. As a result, portions of the atom
proton energy are exposed to the center of the ring. It is quite obvious that
this thermomagnetic phenomena is unique and easily distinguishable from
traditional ferromagnetic and diamagenetic behavior.
THERMOMAGNETIC DEVICES
Schroeder has performed work in artificially produced thermomagnetic fields
which have found practical application in the direct conversion of waste heat
to magnetism. In these devices, a low voltage generating unit is formed by
alternate segments of dissimilar metals arranged in the form of helix formed
into a loop or torus, with heating and cooling of alternate junctions causing a
low voltage but high current flow, current flow being dependent upon
temperature differential between alternate junctions, junction area, and size
of the unit. The voltage generated by heating and cooling junctions of
dissimilar metals is less than one volt but with properly shaped dissimilar
metal segments arranged in a torus fashion with alternate junctions heated and
cooled there is a large current flow.
In humans, the properties of the thermomagnetic field are similar to those
replicated in the device as sited above, namely low voltage and high current
power conditions. This is consistent with the physiological parameters of human
microbiology in that the cell potential is between 45mV and 70mV. As such, any
thermomagnetic field produced by a human being, and hence any induced electron
flow that would result from this field, would be completely compatible with the
existing cell potential found in humans.
STRENGTH - THEORY OF OPERATION
Users of the LifeWave device and technology have experienced immediate and
demonstrable increases in physical strength within minutes after wearing the
LifeWave device. This is not a chemically induced increase in strength such as
would be the case with anabolic steroids, etc. but rather a phenomena in which
existing muscle mass is utilized more efficiently due to the increase in
electron flow. To understand how this phenomena could be possible, if we
examine the striated skeletal muscle system we know that this voluntary group
nerve supply is under conscious control because these nerves are branches of
the peripheral cerebrospinal nervous system (the brain and spinal cord as the
cerebrospinal axis). The muscle fibers themselves are tissues composed of
contractile cells that effect movement based on the excitatory process set up
in nerve fibers by stimuli (the nerve impulse). It is presently believed by
medical research that the nerve impulse is probably in the nature of a wave of
electrochemical disturbances. The efficiency with which large muscle groups are
contracted can be defined as the number of muscle fibers utilized in a
contraction divided by the number of fibers present in that muscle group. It is
presently believed that most humans only contract a small percentage of muscle
fibers in a given group for a given nerve impulse (low efficiency of muscle
mass usage as a function of number of muscle fibers contracted divided by
number of muscle fibers present; not all motor units respond to a given
stimulus).
If now we were to induce a condition in which the total power available for
nerve impulses could be increased so that more muscle fibers could contract for
a given muscle group, the net efficiency of the striated fibers would increase
(more muscle fibers in a group being contracted in a contraction phase; more
motor units responding to a stimulus), and hence usable physical strength could
be improved. It is believed by LifeWave Products, LLC that this is one possible
explanation for the phenomena associated with users of the LifeWave technology,
namely immediate and demonstrable increases in strength and stamina within
minutes of wearing the LifeWave technology.
In support of this explanation, work performed by Mower in the augmentation of
muscle contractility by biphasic stimulation lends validity to this argument.
In this work, Mower sites that enhanced myocardial function is obtained through
biphasic pacing. The combination of cathodal with anodal pulses of either a
stimulating or conditioning nature, preserves the improved conduction and
contractility of anodal pacing while eliminating the drawback of increased
stimulation threshold. The result is a depolarization wave of increased
propagation speed. This increased propagation speed results in superior cardiac
contraction leading to an improvement in blood flow.
Striated muscle may also be stimulated electrically, chemically, mechanically
or by temperature change. Where the muscle fiber is stimulated by a motor
neuron, the neuron transmits an impulse that activates all of the muscle fibers
within its control, that is, those muscle fibers in its motor unit.
Depolarization in one region of the membrane stimulates adjacent regions to
depolarize as well, resulting in a wave of depolarization traveling over the
membrane in all directions away from the site of stimulation. Thus, when a
motor neuron transmits an impulse, all the muscle fibers in its motor unit are
stimulated to contract simultaneously.
The minimum strength to elicit a contraction is called the threshold stimulus.
Once this level of stimulation has been met, the generally held belief is that
increasing the level will not increase the contraction. Additionally, since the
muscle fibers within each muscle are organized into motor units, and each motor
unit is controlled by a single motor neuron, all of the muscle fibers in a
motor unit are stimulated at the same time. However, the whole muscle is
controlled by many different motor units that respond to different stimulation
thresholds. Thus, when a given stimulus is applied to a muscle, some motor
units may respond while others may not.
Therefore, artificial means of externally applied cathodal and anodal pulses of
his biphasic stimulation provides improved and enhanced contraction of striated
muscle.
Similarly, striated muscle stimulation can also serve to preserve the neural
pathway, such that, upon healing of the nerve fibers associated with the
stimulated tissue, patients "remember" how to contract that particular muscle.
In short, for a given stimulus applied to a striated muscle group, not all
motor units will respond to that stimulus, hence not all muscle fibers in that
group will contract for a given stimulus in that contraction phase. Externally
applied biphasic stimulation has demonstrated the capability of augmentation of
the contraction phase for enhanced or improved contractility. In the LifeWave
device, the induced electron flow is created from an external passive device in
a new and novel way, with the end result being an improvement in the
contraction phase for a given muscle group as a result of more motor units
being capable of responding to a given stimulus.
For additional supportive documentation, studies performed and published in the
Journal Of Cardiovascular Electrophysiology (as one example) reinforce the
above as stated.
In addition to the above, it has been well known since the 1970's (Becker) that
maintaining a localized potential in the human body will have the ability to
draw calcium ions to the site. This method has been successfully utilized by
Becker to improve the rate at which broken bones heal.
In the LifeWave device, an induced electron flow could have the same effect in
drawing calcium ions into muscle fibers for the purpose of improving the
efficiency of muscle mass usage.
It is well known that striated muscle is activated by motor nerves under
voluntary control and is concerned with locomotion. It is composed of large,
long fibers that consist of multinucleate cells. Within each fiber are
longitudinal Myofibrils, each with a distinctive pattern of bands caused by the
distribution of the proteins Actin and Myosin. The bands for repeating units
are called sarcomeres. Myofibril banding patterns during contraction and
relaxation phases are easily distinguishable. The contraction of voluntary
muscle is best understood by the "sliding filament" theory. First, the muscle
needs stimulation by an impulse from a motor nerve. Second, the actin and
myosin filaments make contact to form a complex called Actomyosin. This complex
can only be formed in the presence of calcium ions. Since the muscle fibers are
organized into motor units, and each motor unit is controlled by a single motor
neuron, all muscle fibers in a motor unit are stimulated at the same time.
However, the whole muscle group is controlled by many different motor units
that respond to different thresholds. Therefore, for a given muscle
contraction, not all muscle fibers contract during the contraction phase (low
efficiency of muscle mass usage).
The LifeWave technology is a passive device composed of orthomolecular organic
structures arranged parallel to the plane of human thermomagnetic rotation. The
LifeWave device initiates an induced flow of electrons within the user, much in
the same way that a generator produces electricity. This action improves the
efficiency of muscle contraction by recruiting more calcium ions through
attraction (allows for formation of actomyosin) and improves the efficiency of
muscle mass usage (more muscle fibers in a group contract during the
contraction phase). The end result is that within minutes of wearing the
LifeWave device, the user becomes physically stronger.
STAMINA - THEORY OF OPERATION
Users of the LifeWave device and technology have experienced immediate and
demonstrable increases in physical stamina within minutes after wearing the
LifeWave device. Actual results obtained from users have been as low as 8%
improvements to as high as 400% improvements. The passive thermomagnetic
frequency modulation of the LifeWave technology creates a condition in which
the transport of long chain fatty acids across the mitochondrial membrane for
subsequent beta-oxidation and energy production is triggered or improved,
thereby providing the user with increased energy and stamina.
To understand how this phenomena could be possible, let us examine the
metabolic process involving primary energy sources within the human body. For
the purpose of this discussion, we shall focus on fatty acids, a hydrocarbon in
which one of the hydrogen atoms has been replaced by a carboxyl group, also
described as a monobasic aliphatic acid made up of an alkyl radical attached to
a carboxyl group.
Essential fatty acids - those that have been determined to be essential to
maintain health and can not be synthesized by the human body - are by example
the unsaturated fatty acids such as linoleic, linolenic and arachidonic.
The metabolic role of fatty acids may be described in part in that fatty acids
are one of the primary sources of energy for humans, and through
Beta-Oxidation, are broken down into basic units of energy. Of interest here is
that in order for this process to work, fatty acids need to enter the
mitochondria for Beta-Oxidation, and they are unable to penetrate the inner
mitochondrial membrane by themselves.
In addition to lipid metabolism, the mitochondria is involved with protein
synthesis, and by using either phase-contrast microscopy or electron
microscopy, the mitochondrial filaments or rods are seen to be 0.5 micrometers
in diameter. This information is significant in that in the LifeWave
technology, materials and structures must be selected based upon the resonant
and sympathetic frequencies of the mitochondria during both protein synthesis
and lipid metabolism, while not interfering with the other primary objective of
the technology, namely assisting in the recruitment of calcium ions to muscle
fiber sites (for formation of actomyosin).
In the human body, to overcome the problem of the inability of fatty acids to
transport from the cytosol (soluble portion of the cell) across the
mitochondrial membrane, it has been determined by several researchers that
various nutrients are essential to transport long chain fatty acids from the
cytosol across the mitochondrial membrane for fatty acid oxidation/metabolism
and energy production.
However, other methods - other than the use of nutrients - of assisting the
fatty acids across the mitochondrial membrane are possible. In experiments
performed by the author, a method was discovered that involved an active energy
source that is capable of both improving or increasing cell motility and cell
metabolic rate. In this method, a function generator was utilized as a waveform
source and multi-frequency input to a radio transmission unit. The radio
transmitter was used to produce a high frequency carrier wave, while the
function generator provided the "primary" frequencies of study. A linear
amplifier was used to increase the transmitters output to about 300 watts, and
the "antenna" in this system, which is used for transmitting the signal, is a
high impedance plasma-producing receptacle.
In operation, an in vitro analysis was performed in which various modulation
frequencies were studied for there effects on cell motility and mitochondrial
metabolic rate. In summary, it was discovered that by using this equipment in
vitro, both cell motility and mitochondrial metabolic rate could be actively
altered (either decreased or increased) with specific modulation frequencies
(frequencies dependent upon type of cell being investigated, material being
metabolized, etc.)
To obtain the desirable effect of improving cell metabolism passively
(specifically, increasing the rate of fatty acid Beta-Oxidation by allowing
fatty acids to transport across the mitochondrial membrane) the author
constructed a LifeWave device consisting of orthomolecular organic structures
designed to passively interact with the human thermomagnetic field for the
purpose of creating a system of thermomagnetic frequency modulation.
In the experiment described above, the desired effect (increased cell metabolic
rate) was accomplished actively by coupling the desired frequency to a high
energy plasma source. In the LifeWave device, the desired frequency is obtained
passively through material selection, material arrangement and material
processing, with the device coupling to the human body by passive modulation of
the human thermomagnetic field. The end result is that what has been observed
by LifeWave users is dramatic improvements in stamina and energy levels within
minutes of product use.
As an example, in tests performed, users were asked to perform an exercise such
as push-ups, Bench Press, Curl, etc. for 1 set and perform as many repetitions
as possible. In all cases users were able to perform more repetitions when
using LifeWave than without. A representative example would be one user who
performed a Barbell Curl with 100 lbs. for 3 repetitions without LifeWave; the
LifeWave patches were applied and worn for 1 minute, and then the user was able
to perform 9 repetitions with the same 100 lbs.
RESULTS OBTAINED
A group of over 50 individuals was selected from a broad cross section of the
general population. Each individual volunteered to participate in a series of
tests designed for the purpose of collecting initial preliminary data of the
effectiveness of the LifeWave technology. (These tests are separate from
independent lab tests). Some of the information desired from these tests
included change in strength, change in stamina and pain relief. As an initial
indicator, a simple strength resistance test was administered to each
individual by way of conventional physical therapy protocols eg. adduction of
either arm. In every case, every individual demonstrated an improvement in
strength while wearing the LifeWave device.
In more quantitative studies, users were asked to perform tests using both hand
dynamometers and free weights. As representative examples, one individual
produced a nominal hand pressure of 140 lbs. in the control test, followed by
160 lbs. of hand pressure while wearing the LifeWave device. A representative
example with free weights would be an individual who under control conditions
achieved a bench press of 385 lbs., but after wearing the LifeWave device
lifted 415 lbs.
With respect to stamina improvements, gains of 25% and better were achieved by
individuals while wearing the LifeWave device as compared with the control. As
a representative example, an individual who could bench press 200 lbs. for 8
repetitions without the LifeWave device could now bench press the same weight
12 to 16 repetitions while wearing the LifeWave device.
There have also been dozens of reported cases of pain abatement while
individuals have worn the LifeWave device. Examples would include relief from
muscular aches, back aches, head aches, tendinitis, and many others.
The phenomena as observed is not unusual or unknown in other devices; the way
in which the LifeWave device has achieved these results is new and innovative.
For example, in physical therapy electrical signals are utilized for the
purpose of forcing voluntary muscle groups to contract under stimulation. These
devices are commonly known as electrical or electronic muscle stimulators (EMS)
and cause stimulated contraction and relaxation phases of muscle groups. In the
LifeWave device, based on the mode of operation as presented, an improvement in
net efficiency of total muscle mass utilized during a contraction phase may be
achieved due to an increase in electron flow during the wave of electrochemical
disturbances created by the nerve impulse (more motor units responding during a
contraction phase).
In studies that have been conducted with volunteers from a broad cross section
of the general population, in each and every case users experienced an
immediate increase in physical strength directly attributed to the LifeWave
device. In other studies conducted, users of the LifeWave technology have
reported relief from a variety of pain due to muscular aches, headaches and the
like. In all cases, the pain relief occurred in a range of from 2 minutes to 30
minutes.
A REAL WORLD STUDY
The following third party independent study was performed by Joseph A. Goodson
MS, ATC, Head Athletic Trainer at Morehouse College in Atlanta, GA. A summary
of the test and results follows.
A group of 40 athletes were randomly selected to participate in a LifeWave test
study. Athletes were divided into groups as follows: GROUP (1) consisted of 10
track and field athletes, and served as a control group; GROUP (2) consisted of
10 track and field athletes, and served as a test group for the LifeWave
patches; GROUP (3) consisted of 10 football athletes, and served as a control
group; GROUP (4) consisted of 10 football athletes, and served as a test group
for the LifeWave patches.
All athletes in all groups were first required to participate in a base line
study, with said study to be used as a reference for comparison. The base line
data was collected during the first week of the study for all athletes. The
control and test studies were performed the following week for all groups.
For the track and field athletes, the tests performed consisted of 90 minute
sprint sessions. Each athlete was monitored for any potential adverse reaction
such as abnormal change in heart rate, etc. during these tests. At the end of
the tests, the athletes were asked to complete a questionnaire, and report -
subjectively - how they felt during the sprint session and after the sprint
session. Information of interest included how well the athlete was able to
recover between sprints, any muscle cramping during or after sprints, soreness,
and overall feelings of energy after the sessions were completed.
For the football athletes, the tests performed consisted of 60 minute weight
lifting sessions. Each athlete was monitored for any potential adverse reaction
such as abnormal change in heart rate, etc. during these tests. The athletes
performed weight lifting routines designed by the strength coaches, and
consisted of exercises such as Bench Press, Dumbell Flys, Shoulder Press, Lat
Pulldowns, etc., with each exercise being performed for 3 sets of 8
repetitions. During the tests, the athletes were asked to complete a
questionnaire, and report - both objectively and subjectively - what results
were obtained while performing the weight lifting exercises. Information of
interest included how much weight the athlete was able to lift while performing
the exercises, how well the athlete was able to recover between exercises, any
muscle cramping, soreness, and overall feelings of energy after the weight
lifting sessions were completed.
In GROUP (1), the control group for the track and field athletes, there was no
change noted in the athletes performance during the duration of the two week
study. After each 90 minute sprint session, these athletes reported feeling
tired, with most athletes experiencing muscle soreness after the sessions were
completed.
In GROUP (2) the test group for the track and field athletes that used the
LifeWave patches, there was a significant difference in the athletes
performance from the base line study to the test study. While using the
LifeWave patches, all athletes (10/10) reported having more energy while
sprinting, and recovering more quickly between sprints. In addition, the
LifeWave users reported feeling energetic at the end of the sprint session,
with little or no muscle cramping, and no soreness.
In GROUP (3), the control group for the football athletes, there was no change
noted in the athletes performance during the duration of the two week study.
After each 60 minute weight lifting session, these athletes reported feeling
fatigued and sore.
In GROUP (4), the test group for the football athletes that used the LifeWave
patches, there was a significant difference in the athletes performance from
the base line study to the test study. While using the LifeWave patches, all
athletes reported having more energy while weight lifting, as well as
significant improvements in the amount of weight that they were able to lift.
Some representative examples would include: Athlete # 1 performed Dumbell Flys
with 65 lb. dumbells in the base line study for 3 sets of 8 reps, but when
using the LifeWave patches performed Dumbell Flys with 80 lb. dumbells for 3
sets of 8 reps. Athlete # 2 performed a Bench Press with 185 lbs. in the base
line study for 3 sets of 8 reps, but when using the LifeWave patches performed
a Bench Press with 225 lbs. for 3 sets of 8 reps. Athlete # 3 performed a Lat
Pulldown with 90 lbs. in the base line study for 3 sets of 8 reps, but when
using the LifeWave patches performed a Lat Pulldown with 180 lbs. for 3 sets of
8 reps.
APPLICATION
In general, the LifeWave device may be applied virtually anywhere on the human
body for the purpose of promoting a beneficial response. However, as an
interesting note, the most effective locations appear to coincide with points
as described in the system of acupuncture. Because acupuncture points typically
coincide with locations of high electropotential - as discovered by Walter
Rawls - this correlation is not surprising.
For example, in all of the tests administered as cited, the LifeWave device was
placed along the midline of the epigastric region in the depression located in
the center of the chest. In acupuncture, this point is referred to "Shanzhong",
and is described as being located along the Ren channel on the anterior
midline, at the level of the fourth intercostal space. Additionally, a second
point of interest for the placement of the LifeWave device would include the
midline of the umbilical region; "Zhongji", 4 cun below the umbilicus, and the
crossing point of the Ren channel.
If the two patch system is utilized (white patch and tan patch), then the white
patch is applied to the right forearm, and the tan patch is applied to the left
forearm. It has been observed that in most individuals the LifeWave effect is
more dramatic and pronounced with the two patch system as opposed to using only
one patch (white only). This may be understood in terms of total surface area
of exposure, as well as electron flow in one localized region as opposed to
electron flow between two distant sites.
A SIMPLE TEST
For individuals who are new to LifeWave, there are numerous simple and quick
tests that may be performed to demonstrate to the user the validity of the
LifeWave technology. As one example, an individual would first perform an
exercise such as push-ups for as many repetitions as possible (one set only;
perform to failure). The user would then apply the LifeWave patches, wait a few
minutes (or to recovery), and then perform the push-ups for as many repetitions
as possible (one set only; to failure). What most individuals will find is that
when wearing the LifeWave patches it is possible to perform more push-ups than
without LifeWave. In fact, it is typical for users to exceed 25% improvements
with this simple test.
CLINICAL STUDIES
All materials used in the LifeWave patches have been clinically tested for
safety and efficacy. Double Blind placebo controlled studies have been
performed for the purpose of determining the effectiveness of these ingredients
on athletic performance, namely strength and stamina improvements. In tests
performed by LifeWave, over 99% of users experienced improvements in strength
and/or stamina within minutes of using the product. In addition, most
individuals who used LifeWave who suffered from some type of muscular ache or
discomfort found relief within a period of from 2 minutes to 30 minutes.
Further, all materials used in LifeWave products are listed under FDA 21 CFR,
and manufactured at FDA registered facilities.
CONCLUSION
In conclusion, based on the observed and reported beneficial effects that
hundreds of users of the LifeWave devices have relayed to us, it is clear that
a legitimate, beneficial and efficacious physiological augmentation of the
motor unit response and voluntary muscular system is taking place, with the
mode of operation of the LifeWave device being a new and valuable phenomena. As
more data is collected by both LifeWave Products, LLC and third party
laboratories, further insight into this augmentation phase will be achieved.
LifeWave Products, LLC is dedicated to bringing the consumer only safe and
valuable technologies that promote strength, stamina and wellness. Due to the
LifeWave phenomena, the professional athlete, or any individual who desires
increased strength, stamina or pain relief, may achieve these results within
minutes of wearing the LifeWave device technology.
REFERENCES
-
Bassett, et. al., Generation of Electric Potentials by Bone in Response to
Mechanical Stress, Science, 1962
-
Bassett, et. al., Effects of Electric Currents on Bones in Vivo,
Nature, 1964
-
Bassett, et. al., Acceleration of Fracture Repair by Electromagnetic fields: A
Surgically Non-Invasive Method, Ann. NY Acad. Sci., 1974
-
Becker, Stimulation of Partial Limb Regeneration in Rats, Nature,
1972
-
Black, et. al., Electrode Material and Current Density in Electrical Stimulation
of Osteogenesis, BRAGS, 1982
-
Blilie, et. al., Predicting and Validating Cardiothoracic Current Flow Using
Finite Element Modeling, PACE, 1992
-
Chapman, Non-Thoracotomy Internal Defibrillation: Improved Efficacy with
Biphasic Shocks, Circulation, 1991
-
Duarte, et. al., Endothelium-derived oxidative stress may contribute to
exercise-induced muscle damage, Int J Sports Med, 14: 440-443, 1993
-
Feeser, et. al., Strength-Duration and Probability of Success Curves for
Defibrillation with Biphasic Waveforms, Circulation, 82(6), 1990
-
Fisher, et. al, Statistical Tables for Biological, Agricultural, and Medical
Research, Hafner Press, 1953
-
Guyton, Textbook of Medical Physiology, pp. 98-99, 1991
-
Harris, et. al., Acetylcarnitine Formation During Intense Muscular Contraction
in Humans, J Appl Physiol, 63, 1987
-
Hicks, Fundamental Concepts in the Design of Experiments, Holt
Rinehart and Winston, 1973
-
Hulsmann, et. al., Aspects of Fatty Acid Metabolism in Vascular Endothelial
Cells, Biochimie, 70, 1988
-
Jin, et. al., Incomplete Fatty Acid Oxidation, J Biol Chem, 267,
1992
-
Kerner and Hoppel, Fatty Acid Import Into Mitochondria, Biochim
Biophys Acta, 1486:1-17, 2000
-
Lehninger, How Cells Transform Energy, Sci. Amer., Sept. 1961
-
Levy, Induced Osteogenesis by Electrical Stimulation, J. Electrochem Soc.
Electrochemical Science, 1971
-
Meites, Biogenic Amines in the Control of Prolactin and Growth Hormone Secretion,
Psychopharm. Bull., Oct. 1976
-
Nicholson, A Guide to Metabolic Pathways and Co-enzymes, Grand
Island Biologicals
-
Peng, The Design and Analysis of Scientific Experiments, Addison
Wesley, 1967
-
Perna, Verapamil Reverses PTH- or CRF-Induced Abnormal Fatty Acid Oxidation in
Muscle, Kidney, Int, 34, 1988
-
Stastny, et. al., Epidermal Growth Factor: Induction of Ornithine Decarboxylase,
Biochem. Biophys. Acta, 1970
-
Waters, et. al., Treatment of the Hemiplegic Upper Extremity Using Electrical
Stimulation and Biofeedback Training,
Report to the Veterans Administration, Sept., 1980
-
Yap, et. al., An Introduction to Dental Electronic Anesthesia, Quintessence
International, V27, No.5, 1996
ABOUT THE INVENTOR
While conducting undergrad and masters studies at Pace University during the
1980's, Mr. Schmidt received a grant from a private corporation in New Jersey
for the purpose of investigating new and alternative therapies for immunogenic
and non-immunogenic neuroblastomas. This work was performed in conjunction with
the support of the Children’s Hospital Of Philadelphia, and resulted in the
discovery of a new method for selectively targeting C1300 and TBJ cancer cells
without harming the host’s cells.
Over the past 15 years, Mr. Schmidt has been a true innovator in the field of
research and development. He has been credited with inventing such numerous
intellectual properties as a biomimetic battery, organic plastic, novel
ultrasonic probe designs, and new fuel cell anodes amongst others. He has not
only developed new and patent pending methods for the production of Hydrogen
gas on demand from water, but has also made contributions to the integration of
these systems with multi-fuel combustion chambers and bladeless turbine
engines.
In addition, Mr. Schmidt is responsible for pioneering work conducted on behalf
of the Navy for new methods of Oxygen generation. As a result of his
innovations, he was invited to be part of the design team for the Navy’s next
generation submarine.
Amongst his awards, Mr. Schmidt has earned an honorary doctorate degree from
the International Hall Of Fame for accomplishments in both genetics and
metallurgy; he is also a former Board Of Directors member for NuPro
Innovations, Inc., a publicly traded firm engaged in the sale of a proprietary
metaphoric polymer.
At this time, Mr. Schmidt serves as President of LifeWave Products, LLC. He is
the principal investigator and inventor of the LifeWave technology.
|